stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / TECH / Revenue

Bio-Techne Corporation Revenue 2009–2025

Bio-Techne Corporation (TECH) annual revenue by fiscal year, computed from SEC filings. Compound growth +10.0%/yr over 16 years.

Fiscal yearRevenueChange (YoY)
FY 2025$1.22B+5.2%
FY 2024$1.16B+2.0%
FY 2023$1.14B+2.8%
FY 2022$1.11B+18.7%
FY 2021$931.03M+26.0%
FY 2020$738.69M+3.5%
FY 2019$714.01M+11.0%
FY 2018$642.99M+14.2%
FY 2017$563.00M+12.8%
FY 2016$499.02M+10.3%
FY 2015$452.25M+26.4%
FY 2014$357.76M+15.2%
FY 2013$310.57M-1.3%
FY 2012$314.56M+8.5%
FY 2011$289.96M+7.8%
FY 2010$269.05M+1.9%
FY 2009$263.96M

Source: Bio-Techne Corporation SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Bio-Techne Corporation

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Bio-Techne Corporation — frequently asked questions

What is Bio-Techne Corporation's revenue?

Bio-Techne Corporation (TECH) reported revenue of $1.22B for fiscal year 2025, per its SEC filings.

How has Bio-Techne Corporation's revenue changed over time?

Between fiscal 2009 and 2025, TECH's revenue grew at roughly 10.0% per year (compound annual rate), from $263.96M to $1.22B.

Where does this data come from?

Figures are computed from Bio-Techne Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More TECH financial history

Full TECH fundamentals page → · All 1,500+ companies →